We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Lam Research (LRCX) Beats on Q1 Earnings, Q2 Outlook Positive
Read MoreHide Full Article
Lam Research Corporation (LRCX - Free Report) reported first-quarter fiscal 2019 non-GAAP earnings of $3.36 per share, which beat the Zacks Consensus Estimate by 15 cents. However, the figure decreased 36.7% sequentially.
Adjusted revenues of $2.33 billion comfortably surpassed the Zacks Consensus Estimate of $2.30 billion and were slightly above the mid-point of the company’s guidance. However, the figure decreased 25.4% sequentially and 5.9% year over year.
Following the results, shares of the company jumped 7% in after-hours trading. Lam Research shares have lost 18.9% on a year-to-date basis compared with the industry’s decline of 14.3%.
Quarter Details
In the quarter, Japan, China, Korea and Taiwan accounted for 29%, 25%, 16% and 12% of total revenues, respectively. Southeast Asia, United States and Europe contributed 9%, 5% and 4% of total revenues, respectively.
Memory accounted for 77% of total system revenues. Non-volatile memory revenues represented approximately 51% of system revenues, while DRAM represented 26%. DRAM spending remained focused on conversions to both the 1x and 1y nanometer (nm) node.
Lam Research Corporation Price, Consensus and EPS Surprise
Foundry segment was stronger in the quarter, accounting for 17% of system revenues. Logic and other segment contributed 6% of system revenues.
Non-GAAP gross margin contracted 170 basis points (bps) on a sequential basis to 46.4%.
Non-GAAP operating expenses were $450.5 million, down 11.2% sequentially. As percentage of total revenues, operating expenses increased 310 basis points (bps) sequentially to 19.3%.
Research & development (R&D) related spending accounted for almost two-third of operating expenses.
Adjusted operating margin contracted 480 bps sequentially to 27% but was better than management’s guidance, primarily due to stronger gross margin and lower spending.
Balance Sheet & Cash Flow
As of Sep 23, 2018, cash and cash equivalents, short-term investments, and restricted cash and investments balances decreased to $3.9 billion compared with $5.2 billion as of Jun 24, 2018.
Cash flow from operating activities was $720.3 million, up from $718.4 billion in the last reported quarter. Capital expenditures were $56 million, down from $80 million in the previous quarter.
During the quarter, Lam Research bought back shares worth $1.7 billion and paid dividends of $174 million.
Guidance
For second-quarter fiscal 2019, Lam Research projects revenues of $2.5 billion (+/- $150 million). The Zacks Consensus Estimate is pegged at $2.53 billion. Management expected modest increase in customer spending across multiple segments.
Gross margin is predicted at around 46% (+/-1%), while operating margin is expected to come in at 27.5% (+/-1%).
Non-GAAP earnings are projected at $3.65 (+/- 20 cents) per share on a share count of nearly 163 million. The Zacks Consensus Estimate is pegged at $3.77.
Management stated that Wafer Fab Equipment (WFE) expectations continue to grow slightly on a year-over-year basis in 2018. WFE is stronger in logic but slightly weaker in NAND and foundry.
Lam Research stated that it is looking into 14 new fab projects in calendar 2019. Management expects first half of 2019 to be strong than the second half of 2018.
Lam Research provided an optimistic long-term outlook. The rapid proliferation of next generation device and systems architectures, and the expansion of the materials in chip design and manufacturing creates compelling opportunities for the company’s etch and deposition expertise.
Moreover, the company expects to eventually hit long-term operating margin target of 32-33%, with increase in DRAM, logic and foundry revenues.
Lam Research expects about 1 million wafer starts per month of incremental capacity in the system related to non-volatile memory, over the long term.
Zacks Rank & Stocks to Consider
Currently, Lam Research carries a Zacks Rank #4 (Sell).
Long-term earnings growth for ASML, Advanced Energy Industries and Broadcom is currently pegged at 18.74%, 10% and 13.32%, respectively.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Lam Research (LRCX) Beats on Q1 Earnings, Q2 Outlook Positive
Lam Research Corporation (LRCX - Free Report) reported first-quarter fiscal 2019 non-GAAP earnings of $3.36 per share, which beat the Zacks Consensus Estimate by 15 cents. However, the figure decreased 36.7% sequentially.
Adjusted revenues of $2.33 billion comfortably surpassed the Zacks Consensus Estimate of $2.30 billion and were slightly above the mid-point of the company’s guidance. However, the figure decreased 25.4% sequentially and 5.9% year over year.
Following the results, shares of the company jumped 7% in after-hours trading. Lam Research shares have lost 18.9% on a year-to-date basis compared with the industry’s decline of 14.3%.
Quarter Details
In the quarter, Japan, China, Korea and Taiwan accounted for 29%, 25%, 16% and 12% of total revenues, respectively. Southeast Asia, United States and Europe contributed 9%, 5% and 4% of total revenues, respectively.
Memory accounted for 77% of total system revenues. Non-volatile memory revenues represented approximately 51% of system revenues, while DRAM represented 26%. DRAM spending remained focused on conversions to both the 1x and 1y nanometer (nm) node.
Lam Research Corporation Price, Consensus and EPS Surprise
Lam Research Corporation Price, Consensus and EPS Surprise | Lam Research Corporation Quote
Foundry segment was stronger in the quarter, accounting for 17% of system revenues. Logic and other segment contributed 6% of system revenues.
Non-GAAP gross margin contracted 170 basis points (bps) on a sequential basis to 46.4%.
Non-GAAP operating expenses were $450.5 million, down 11.2% sequentially. As percentage of total revenues, operating expenses increased 310 basis points (bps) sequentially to 19.3%.
Research & development (R&D) related spending accounted for almost two-third of operating expenses.
Adjusted operating margin contracted 480 bps sequentially to 27% but was better than management’s guidance, primarily due to stronger gross margin and lower spending.
Balance Sheet & Cash Flow
As of Sep 23, 2018, cash and cash equivalents, short-term investments, and restricted cash and investments balances decreased to $3.9 billion compared with $5.2 billion as of Jun 24, 2018.
Cash flow from operating activities was $720.3 million, up from $718.4 billion in the last reported quarter. Capital expenditures were $56 million, down from $80 million in the previous quarter.
During the quarter, Lam Research bought back shares worth $1.7 billion and paid dividends of $174 million.
Guidance
For second-quarter fiscal 2019, Lam Research projects revenues of $2.5 billion (+/- $150 million). The Zacks Consensus Estimate is pegged at $2.53 billion. Management expected modest increase in customer spending across multiple segments.
Gross margin is predicted at around 46% (+/-1%), while operating margin is expected to come in at 27.5% (+/-1%).
Non-GAAP earnings are projected at $3.65 (+/- 20 cents) per share on a share count of nearly 163 million. The Zacks Consensus Estimate is pegged at $3.77.
Management stated that Wafer Fab Equipment (WFE) expectations continue to grow slightly on a year-over-year basis in 2018. WFE is stronger in logic but slightly weaker in NAND and foundry.
Lam Research stated that it is looking into 14 new fab projects in calendar 2019. Management expects first half of 2019 to be strong than the second half of 2018.
Lam Research provided an optimistic long-term outlook. The rapid proliferation of next generation device and systems architectures, and the expansion of the materials in chip design and manufacturing creates compelling opportunities for the company’s etch and deposition expertise.
Moreover, the company expects to eventually hit long-term operating margin target of 32-33%, with increase in DRAM, logic and foundry revenues.
Lam Research expects about 1 million wafer starts per month of incremental capacity in the system related to non-volatile memory, over the long term.
Zacks Rank & Stocks to Consider
Currently, Lam Research carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the broader computer and technology sector include ASML Holding (ASML - Free Report) , Advanced Energy Industries (AEIS - Free Report) and Broadcom (AVGO - Free Report) . All the three stocks have a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Long-term earnings growth for ASML, Advanced Energy Industries and Broadcom is currently pegged at 18.74%, 10% and 13.32%, respectively.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>